Guardant Health, Inc. Share Price
NASDAQ: GH | Large CapGuardant Health, Inc. Stock Performance
Open $161.88 | Prev. Close $157.74 | Circuit Range N/A |
Day Range $161.88 - $169.12 | Year Range $48.27 - $176.15 | Volume 1,41,853 |
Average Traded $166.83 |
Guardant Health, Inc. Share Price Today
As of 10 August 2026, Guardant Health, Inc.'s share price is $168.46. The stock opened at $161.88, compared to its previous close of $157.74. During today's trading session, Guardant Health, Inc.'s share price traded between $161.88 and $169.12, with an average price of $165.50. Over the past 52 weeks, the stock has recorded a high of $176.15 and a low of $48.27. In terms of performance, Guardant Health, Inc.'s share price has risen by 79.29% over the last six months and is up 150.13% on a year-on-year basis.
Guardant Health, Inc. Share Price Chart
Guardant Health, Inc. Stock Fundamentals & Key Indicators
Market Cap $21.12B | PE Ratio (TTM) -50.74 | Dividend Yield N/A |
EPS (TTM) $-3.32 | Revenue (TTM) $982.02M | Return On Equity (TTM) 419.18% |
Profit Margin -42.39% | Debt to Equity -3.05 | Quarterly Earnings Growth YoY 13.95% |
Guardant Health, Inc. Quarterly Profit & Loss
All figures in USD
Guardant Health, Inc. Annual Profit & Loss
All figures in USD
About Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform. In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Guardant Health, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $158.46 | $168.45 | +4.06% |
Jul 2026 | $159.69 | $161.87 | +7.81% |
Jun 2026 | $127.59 | $150.14 | +15.72% |
May 2026 | $87.91 | $129.74 | +48.82% |
Apr 2026 | $94.81 | $87.18 | -5.65% |
Mar 2026 | $92.89 | $92.41 | -1.65% |
Feb 2026 | $113.23 | $93.96 | -17.65% |
Jan 2026 | $101.98 | $114.10 | +11.74% |
Dec 2025 | $106.41 | $102.11 | -5.79% |
Nov 2025 | $93.72 | $108.39 | +16.52% |
Oct 2025 | $62.41 | $93.03 | +48.91% |
Sep 2025 | $65.81 | $62.47 | -7.25% |
GH Share Price FAQs
What is Guardant Health, Inc. share price today?
What is the 52 week high and 52 week low of Guardant Health, Inc. stock?
What is GH's market capitalisation today?
What is GH's net income for the last quarter?
What is the 5 year returns of GH?
What is the high & low stock price of GH today?
Can I buy GH shares in India?